started · updated
Russia to invest 2 trillion rubles in anti-aging research
Russia has launched an ambitious research program aimed at significantly extending human life and eventually overcoming biological aging limits. The initiative involves investing more than 2 trillion rubles into studies focused on cellular regeneration, anti-aging treatments, and the laboratory creation of human organs.
Maria Vorontsova, an endocrinologist and director of the Institute for Medical Research and Education at Moscow State University, is a central figure in this initiative. Vorontsova, who has been sanctioned by the US Treasury Department, has outlined a two-phase strategy. The first phase aims to increase human longevity to between 85 and 90 years through healthy lifestyle habits and medical monitoring. The second phase seeks to intervene in biological processes to bypass natural aging constraints.
During a recent forum at the Skolkovo School of Management, Vorontsova discussed scientific advancements that could potentially “cheat God or nature.” The program includes experimentation with what researchers call an “anti-aging vaccine” and the development of human organs in small laboratories.
Entities
Maria Vorontsova · Moscow State University · Russia · Skolkovo School of Management · US Treasury Department